Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT03991884 · COMPLETED

Trial details

NCT number: NCT03991884
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent B Acute Lymphoblastic Leukemia Recurrent B Lymphoblastic Lymphoma Refractory B Acute Lymphoblastic Leukemia Refractory B Lymphoblastic Lymphoma

Start date: 2019-09-24
Primary completion: 2022-10-20
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.